Andrea Decensi
Chemoprevention Unit
European Institute of Oncology
via Ripamonti 435
20141
Italy
Name/email consistency: high
- Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Decensi, A., Maisonneuve, P., Rotmensz, N., Bettega, D., Costa, A., Sacchini, V., Salvioni, A., Travaglini, R., Oliviero, P., D'Aiuto, G., Gulisano, M., Gucciardo, G., del Turco, M.R., Pizzichetta, M.A., Conforti, S., Bonanni, B., Boyle, P., Veronesi, U. Circulation (2005)
 - A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. Decensi, A., Bonanni, B., Baglietto, L., Guerrieri-Gonzaga, A., Ramazzotto, F., Johansson, H., Robertson, C., Marinucci, I., Mariette, F., Sandri, M.T., Daldoss, C., Bianco, V., Buttarelli, M., Cazzaniga, M., Franchi, D., Cassano, E., Omodei, U. Clin. Cancer Res. (2004)
 - A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. Decensi, A., Robertson, C., Viale, G., Pigatto, F., Johansson, H., Kisanga, E.R., Veronesi, P., Torrisi, R., Cazzaniga, M., Mora, S., Sandri, M.T., Pelosi, G., Luini, A., Goldhirsch, A., Lien, E.A., Veronesi, U. J. Natl. Cancer Inst. (2003)
 - Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide. Decensi, A., Veronesi, U., Miceli, R., Johansson, H., Mariani, L., Camerini, T., Di Mauro, M.G., Cavadini, E., De Palo, G., Costa, A., Perloff, M., Malone, W.F., Formelli, F. Clin. Cancer Res. (2003)
 - Breast cancer prevention trials using retinoids. Decensi, A., Serrano, D., Bonanni, B., Cazzaniga, M., Guerrieri-Gonzaga, A. J. Mammary. Gland. Biol. Neoplasia (2003)
 - Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Decensi, A., Omodei, U., Robertson, C., Bonanni, B., Guerrieri-Gonzaga, A., Ramazzotto, F., Johansson, H., Mora, S., Sandri, M.T., Cazzaniga, M., Franchi, M., Pecorelli, S. Circulation (2002)
 - Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer. Decensi, A., Johansson, H., Miceli, R., Mariani, L., Camerini, T., Cavadini, E., Di Mauro, M.G., Barreca, A., Gonzaga, A.G., Diani, S., Sandri, M.T., De Palo, G., Formelli, F. Cancer Epidemiol. Biomarkers Prev. (2001)
 - Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point. Decensi, A., Torrisi, R., Bruno, S., Costantini, M., Curotto, A., Nicolò, G., Malcangi, B., Baglietto, L., Bruttini, G.P., Gatteschi, B., Rondanina, G., Varaldo, M., Perloff, M., Malone, W.F., Bruzzi, P. Cancer Epidemiol. Biomarkers Prev. (2000)
 - Update on tamoxifen to prevent breast cancer. The Italian Tamoxifen Prevention Study. Decensi, A., Bonanni, B., Rotmensz, N., Robertson, C., Guerrieri-Gonzaga, A., Mora, S., Diani, S., Cazzaniga, M., Costa, A. Eur. J. Cancer (2000)
 









